A computational molecular docking study of camptothecin similars as inhibitors for topoisomerase 1
- 21 September 2020
- journal article
- research article
- Published by Springer Nature in Structural Chemistry
- Vol. 32 (2) , 689-697
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- QSAR, docking and ADMET studies of camptothecin derivatives as inhibitors of DNA topoisomerase‐IJournal of Chemometrics, 2013
- Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer AgentsPLOS ONE, 2011
- Evaluation of Two Models for Human Topoisomerase I Interaction with dsDNA and Camptothecin DerivativesPLOS ONE, 2011
- Empirical Scoring Functions for Advanced Protein−Ligand Docking with PLANTSJournal of Chemical Information and Modeling, 2009
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Mechanisms of Camptothecin Resistance by Human Topoisomerase I MutationsJournal of Molecular Biology, 2004
- GEMDOCK: A generic evolutionary method for molecular dockingProteins: Structure, Function, and Bioinformatics, 2004
- Cancer Therapeutics: Understanding the Mechanism of ActionToxicologic Pathology, 2004
- Satisfying Hydrogen Bonding Potential in ProteinsJournal of Molecular Biology, 1994
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966